MREO
NASDAQ
$0.31
Mereo Biopharma Group Plc (MREO)
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops and markets therapeutic products for the treatment of oncology and rare diseases in the UK and internationally. The company is headquartered in London, the United Kingdom.
Sector:
Healthcare
Industry:
Biotechnology
Target: $1.74 (+468.81%)
Market Cap
$53M
Free Cash Flow Yield
-51.26%
Beta (5Y)
1.23
Price Chart
Valuation
Market Cap$53M
P/S104.68
P/B1.47
Profitability
Total Revenue (TTM)$500K
Gross Profit (TTM)$367K
EBITDA-$38M
Operating Margin-7182%
EPS-$0.26
Financial Health
Free Cash Flow Yield-51.26%
Growth & Risk
Beta (5Y)1.23
Sharpe Ratio-0.14